Oscar Health stock rises 2% on strong earnings beat and raised outlook

On Thursday, Oscar Health Inc. (NYSE:OSCR) announced that it had reported strong third quarter earnings, surpassing analyst expectations. The health insurance company revealed that it had earned $0.49 per share, compared to the analyst consensus estimate of -$0.14. Revenue for the quarter amounted to $5.14 billion, exceeding the forecasted $4.69 billion. In response to these impressive results, Oscar Health's shares saw a 2.59% increase in pre-market trading.

The company's revenue growth was particularly noteworthy, increasing by 72% year-over-year from $2.99 billion in the third quarter of 2025. In addition to the strong earnings report, Oscar Health also raised its full-year 2026 revenue guidance, expanding the range to $19.0 billion to $19.3 billion, with a midpoint of $19.15 billion. This figure surpassed the analyst consensus of $18.73 billion.

CEO Mark Bertolini attributed the company's strong performance to its historical trend, stating that Oscar Health is "on track to deliver the strongest year of financial performance in our history." The CEO further emphasized the company's commitment to leading the rapidly developing individual market in America, highlighting Oscar Health's robust medical loss ratio of 84.0% and its cost-cutting efforts, which resulted in a decreased selling, general, and administrative expense ratio of 14.0%.